Lubiprostone: new treatment for chronic idiopathic constipation

Lubiprostone (Amitiza) increases intestinal motility and is licensed for the treatment of chronic idiopathic constipation. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse events and Dr Alex Ford discusses its place in therapy.

Lubiprostone new treatment for chronic idiopathic constipation

Add yours ↓
Web design and marketing agency Leamington Spa